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OBJECTIVES The purpose of this study was to examine whether exercise training stimulates a generalized
improvement in vascular function in patients with type 2 diabetes mellitus.
BACKGROUND Exercise is often recommended for patients with type 2 diabetes to improve physical
conditioning and glycemic control. This study examined the effect of eight weeks of exercise
training on conduit and resistance vessel function in patients with type 2 diabetes, using a
randomized crossover design.
METHODS Both resistance vessel endothelium-dependent and -independent functions were determined
by forearm plethysmography and intrabrachial infusions of acetylcholine (ACh) and sodium
nitroprusside (SNP), respectively, in 16 patients with type 2 diabetes. Conduit vessel
endothelial function was assessed in 15 of these patients using high-resolution ultrasound and
flow-mediated dilation of the brachial artery; glyceryl trinitrate (GTN) was used as an
endothelium-independent dilator.
RESULTS Flow-mediated dilation increased from 1.7 6 0.5% to 5.0 6 0.4% following training (p ,
0.001). The forearm blood flow ratio to ACh was significantly improved (analysis of variance,
p , 0.05). Responses to SNP and GTN were unchanged. Endothelium-dependent
vasodilation was enhanced in both conduit and resistance vessels.
CONCLUSIONS If endothelial dysfunction is an integral component of the pathogenesis of vascular disease, as
currently believed, this study supports the value of an exercise program in the management of
type 2 diabetes. (J Am Coll Cardiol 2001;38:860–6) © 2001 by the American College of
Cardiology
Mortality from type 2 diabetes is largely attributable to
atherosclerotic macrovascular complications, whereas mi-
crovascular dysfunction and consequent retinopathy, neu-
ropathy and nephropathy contribute significantly to mor-
bidity. The importance of the endothelium in maintaining
normal vascular function has been increasingly recognized.
Endothelium-dependent vasodilation, largely dependent
upon nitric oxide (NO), is not only impaired with overt
vascular disease but is also associated with conventional
vascular risk factors (1) and may improve with appropriate
interventions (2–4). Many investigators consider endothe-
lial dysfunction to be an early and integral manifestation of
atherosclerotic disease and that improvement in endothelial
function reflects antiatherogenic benefit (5). In noninsulin-
dependent type 2 diabetic patients, NO-related dilator
endothelial function has usually (6,7), although not invari-
ably (8), been found to be depressed.
Exercise training in animals improves NO-dependent
vasodilation (9) and upregulates expression of the constitu-
tive NO-synthase (10,11). In addition, recent studies indi-
cate that exercise may improve endothelial function in
normal subjects (12) and patients with chronic heart failure
(13–16). Although exercise training is recommended for
subjects with type 2 diabetes to modify body composition, to
maintain cardiorespiratory fitness and to improve glucose
tolerance (17), no studies have investigated its effect on
vascular function. The purpose of the present study was to
determine whether an eight-week exercise training program
improved endothelium-dependent or -independent resis-
tance or conduit vessel function.
METHODS
Patients and screening measures. Sixteen patients (14
men, 2 women), aged 52 6 2 (SE) years, were recruited.
The following were excluded: smokers; those with renal
impairment or proteinuria, hepatic impairment, gout or
hyperuricemia; hypercholesterolemia (total cholesterol
.6.0 mmol/l21) or hypertension (systolic blood pressure
.160 mm Hg). Five patients were taking angiotensin-
converting enzyme (ACE) inhibitors; two were taking
lipid-lowering therapy; two were taking aspirin, and all but
one were taking an oral hypoglycemic (metformin, 3;
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gliclazide, 3; glipizide, 1; combined therapy, 8). Medica-
tions were not altered during the course of the trial. The
study protocol was approved by the Royal Perth Hospital
Ethics Committee, and patients gave written, informed
consent.
Study design. Patients were randomized to an 8-week
exercise or nontraining period, and the experimental mea-
sures in the following text were assessed at entry, after 8
weeks and, following crossover, 16 weeks after entry.
Vascular function assessment protocols. Vascular func-
tion was assessed 4 h after medication use, fasting and
abstaining from alcohol or caffeinated beverages for 12 h
and, for individual patients, at the same time of the day.
Both endothelium-dependent and -independent vascular
functions in resistance vessels were assessed in all 16
patients, whereas high-resolution vascular ultrasonography
of conduit vessels was performed in 15 patients (one patient
was unavailable for postexercise training assessment).
Assessment of resistance vessel function. Investigations
were conducted in a quiet, temperature-controlled labora-
tory. Patients lay supine while pneumatic pressure cuffs
(SC10 and SC5, D.E. Hokanson, Bellevue, Washington)
and strain-gauges (SG24, Medasonics, Mountain View,
California) were positioned for the measurement of forearm
blood flow (FBF) by the technique of strain-gauge plethys-
mography. The cuffs on both wrists were connected to a
flow-regulated source of compressed air, and arm cuffs were
connected to a rapid inflation device (E20, D.E. Hokan-
son). The strain-gauges were placed 8 to 10 cm from the
olecranon process of each forearm, and care was taken to
ensure that they were at the same level on each arm. Output
from the gauges passed through an amplifier (SPG16,
Medasonics) and was sampled by an online microcomputer
at a rate of 75 Hz before being displayed on a monitor in
real time. A software program coordinated the acquisition,
storage and display of data as well as inflation and deflation
of the arm cuffs, ensuring that blood flow measures were
synchronized with cuff inflation during recording periods.
Following cuff placement, a 20-gauge arterial cannula
(Arrow, Reading, Pennsylvania) was introduced into the
brachial artery of the nondominant arm, under local anes-
thesia with ,2 ml of 1% lidocaine (Astra Pharmaceuticals,
Sydney, Australia), to transduce pressure, for the infusion of
drugs or physiological saline and for sampling of arterial
blood. Intra-arterial pressure was measured continuously
(Transpac, Abbot Laboratories, Sligo, Ireland) throughout
the study. Drug infusions were administered using a
constant-rate infusion pump (IVAC 770, IVAC, Califor-
nia). Acetylcholine (ACh) (Miochol; Ciba Vision, Austra-
lia) was infused at 10, 20 and 40 mg z min21, each for 3 min,
followed by sodium nitroprusside (SNP) (David Bull Lab-
oratories, Melbourne, Australia) at 2, 4 and 8 mgzmin21,
each for 3 min. All solutions were prepared aseptically from
sterile stock solutions or ampules immediately before infu-
sion into the brachial artery.
The study protocol and time frame were identical for
every patient. Baseline measurements started 25 min after
cannulation of the brachial artery. Blood flow measurements
were taken by inflating the wrist cuffs to 220 mm Hg, to
exclude the hands from the circulation, and by rapidly
inflating the upper arm cuffs to 45 mm Hg for 10 out of
every 15 s throughout the baseline and drug infusion
periods. Output from the strain-gauges was stored, and the
average of the last five flow measurements from each period
was used for analysis. Between infusions, the cuffs were
deflated, allowing at least 15 min for the FBF to recover
from the preceding infusion before further baseline mea-
sures were recorded.
Assessment of conduit vessel function. Patients lay su-
pine for 20 min before the first ultrasound scan was
recorded. Brachial artery diameter, mean arterial pressure
(MAP) and heart rate (HR) were determined at rest, after
flow-mediated dilation (FMD) induced by reactive hyper-
emia and after administration of glyceryl trinitrate (GTN).
The monitored, nondominant arm was positioned at an
arm-to-torso angle of 80° with the distal forearm supinated
and immobilized by foam supports encompassing the limb.
A three-lead electrocardiogram (ECG) was used to contin-
uously monitor HR, and MAP was measured using an
automated sphygmomanometer on the contralateral arm
(Dinamap, 8100, Critikon, Tampa, Florida). A 12-MHz
multifrequency linear array probe attached to a high-
resolution ultrasound machine (Aspen, Acuson, Mountain
View, California) was used to visualize the artery in the
distal third of the upper arm. The probe was held in a
constant stable position for the duration of the trial by a
stereotactic clamp, and its precise location was recorded and
standardized for the repeat session by measurement of the
proximal and distal distance of the probe from the radial.
Finally, a rapid inflation/deflation pneumatic cuff, placed
around the forearm immediately distal to the humeral
epicondyles, was used to provide a stimulus for FMD.
Ultrasonic parameters were set to optimize longitudinal,
B-mode images of the lumen/arterial wall interface, with
the focus zone positioned on the near wall to assist visual-
ization of the lumen/arterial wall interface. Once set,
operating parameters remained constant throughout each
session.
Abbreviations and Acronyms
ACE 5 angiotensin-converting enzyme
ACh 5 acetylcholine
ANOVA 5 analysis of variance
ECG 5 electrocardiogram
FBF 5 forearm blood flow
FMD 5 flow-mediated dilation
GTN 5 glyceryl trinitrate
HR 5 heart rate
L-NMMA 5 NG-monomethyl-L-arginine
MAP 5 mean arterial pressure
NO 5 nitric oxide
SNP 5 sodium nitroprusside
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After the initial 20-min stabilization period, baseline
scans assessing vessel diameter were recorded over 2 min.
The proximal forearm cuff was then inflated to 250 mm Hg
for 5 min. Dilation of a forearm conduit artery stimulated by
reactive hyperemia, resulting from this ischemic stimulus,
provides a measure of endothelium-dependent, largely NO-
mediated vasodilation (18). The B-mode measures com-
menced 30 s before cuff deflation and continued for a period
of 3 min after cuff deflation.
When vascular diameter had returned to baseline levels
after a period of 15 min, a second baseline scan was
recorded. This was followed by sublingual administration of
GTN (400 mg), which provides an index of endothelium-
independent NO dilation.
Post-test analysis of brachial artery diameter was per-
formed using custom-designed edge-detection and wall-
tracking software that is independent of investigator bias.
Briefly, videotaped images were captured to computer
memory using a digital frame grabber. The ECG-gated
B-mode frames were then assessed by automated edge
detection software, which employs a pixel density and
frequency distribution algorithm. Images that coincided
with the peak of R waves were analyzed, with approximately
600 individual diameter measures along the artery being
assessed per image. The average of these individual diameter
measures was calculated and a polynomial regression was
then fitted to diameters obtained from successive R waves.
Both FMD and GTN values were calculated as percent
change from preceding baseline data.
Exercise training regimen. The eight-week regimen con-
sisted of three 1-h sessions of whole body exercise each
week, concentrating on the large muscle groups of the lower
limbs. Selected torso and upper body exercises, as long as
they did not involve hand gripping or forearm exercise, were
also included. Training involved a combination of cycle
ergometry, treadmill walking and resistance training, the
latter performed on weight-stack machines (Pulsestar,
Cheshire, United Kingdom). An exercise “circuit” consisted
of seven resistance exercises alternated with eight aerobic
exercise (cycling) stations, each performed for 45 s. To
conclude the circuit, patients spent 5 min walking on a
treadmill. The seven resistance exercises consisted of dual
seated leg press, left and right hip extension, pectoral
exercises, shoulder extension, seated abdominal flexion and
dual leg flexion. Both the intensity and the duration of the
exercise program were progressively increased during the
first two to three weeks of the program, as individually
tolerated. Thereafter, cycle ergometry and treadmill walking
were maintained at 70% to 85% of peak HR, determined
during a graded incremental exercise test performed to peak
endurance capacity (V˙O2 peak) before entry to the study.
Resistance training intensity was maintained at 55% to 65%
of pretraining maximum voluntary contraction, which was
determined for all seven exercises in the circuit.
Analysis of data. All blood flow measures were analyzed by
an investigator who was blinded with respect to patient
identification. Although the low doses of drugs infused in
the study produce negligible systemic effects and showed no
effect on blood pressure or HR, it is still desirable to exclude
an alteration in overall hemodynamics as a cause of the flow
changes seen in the infused forearm. Thus, FBF was
measured simultaneously in both arms, although only one
arm was infused, and the noninfused arm served as a
control. As in earlier studies (2,3,19,20), FBF in the infused
arm is described as a ratio to that in the noninfused arm.
Changes in the ratio during ACh and SNP infusions are
expressed as percentage changes from the baseline immedi-
ately preceding each drug administration (21). In addition,
FBF is expressed in absolute units (mlz100 ml21zmin21).
The responses to intrabrachial infusions after exercise
training were compared to nontraining responses using
two-way analysis of variance (ANOVA) with repeated
measures performed on the three dose levels of ACh and
SNP. All other comparisons of training and nontraining
periods were undertaken using the Student paired two-sided
t test. Both FMD and GTN responses before and after
exercise training were also compared using the Student
paired t test. Pearson product moment correlation coeffi-
cients were used to compare changes in the highest dose
responses to ACh and changes in the FMD responses,
before and after training, to changes in glycated hemoglobin
and fasting blood glucose. Results are expressed as means 6
SE. A p value ,0.05 was considered significant.
RESULTS
Six of the 16 patients were randomized to receive exercise
training first. All patients completed 24 exercise sessions,
and no significant adverse events occurred. There was no
effect of the order of randomization on the variables
measured, so results after exercise training were compared
with those after the nonexercise period irrespective of order
of administration.
General effects of exercise training. There were no sig-
nificant differences in plasma total, high-density lipoprotein
or low-density lipoprotein cholesterol, triglycerides or rest-
ing MAP following training. Resting HR, glycated hemo-
globin and fasting blood glucose were significantly lower (all
p , 0.05; Table 1). Peak V˙O2 increased as a result of
training, from 23.1 6 1.2 to 24.8 6 1.4 mlzkg21zmin21
(p , 0.05).
Forearm conduit vessel function. Baseline brachial artery
diameter was not significantly different before and after the
training period (4.5 6 0.2 vs. 4.3 6 0.2 mm, p 5 0.08). The
FMD of the brachial artery following forearm ischemia,
which is largely endothelium and NO dependent, signifi-
cantly increased after exercise training, from 1.7 6 0.5% to
5.0 6 0.4% (p , 0.001). In contrast, endothelium-
independent vasodilation to GTN was not significantly
different (13.1 6 1.5% vs. 13.7 6 2.0%, p 5 0.7; Fig. 1). No
significant differences occurred in the change in FMD,
before and after training, between patients who were taking
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ACE inhibitors (n 5 5), compared to those who were not
(n 5 10; 2.4 6 0.5 vs. 3.7 6 0.7%, p 5 0.3). Due to the
small number of patients taking lipid-lowering medication
(n 5 2), a t test was not performed to assess the influence of
this medication, but the change in FMD before and after
training in those taking medication was 2.9 6 1.9%,
compared to 3.3 6 0.6% in patients who were not medi-
cated.
Forearm resistance vessel function. Baseline FBF re-
sponses in the infused limb did not significantly differ before
and after training (2.88 6 0.32 vs. 2.13 6 0.22 mlz100 ml
forearm21zmin21, p 5 0.07). The FBF responses to the
three dose levels of ACh, related to the preinfusion baseline
levels, were on the average higher, but not significantly so,
after training (p 5 0.06, ANOVA; Table 2). The interac-
tion between treatment and dose was also nonsignificant
(p 5 0.2). However, the preferred method of analysis relates
the flow in the infused arm to that in the noninfused arm
(2–4,19,21,22), and the ratios at the three dose levels of
ACh were significantly greater following training (p , 0.05,
ANOVA; Fig. 2). The interaction between treatment and
dose was not significant (p 5 0.2). The effect of exercise
training on responses to SNP was not significant (p 5 0.6,
ANOVA; Fig. 2), nor was the interaction between treat-
ment and dose (p 5 0.2). Responses were not dependent on
the order of training and nontraining periods, and there was
no difference between the nontrained data of those trained
first or second (Fig. 3).
Relationship between changes in vascular function and
glycemic control. Following training, the change in FBF
in response to the highest dose of ACh was not significantly
correlated with either the change in glycated hemoglobin
(r 5 0.09, p . 0.1) or in fasting blood glucose concentration
(r 5 0.14, p . 0.1). Similarly, change in the FMD response,
before and after training, was not significantly correlated
with either the change in glycated hemoglobin (r 5 20.32,
p . 0.1) or that in fasting blood glucose concentration (r 5
20.10, p . 0.1).
DISCUSSION
The principal new finding of this study was that exercise
training improved indices of endothelial function in patients
with type 2 diabetes. The FBF response to ACh and FMD
of the brachial artery, both of which are endothelium and
Table 1. Patient Characteristics Following the Trained and
Untrained Periods
Untrained Trained
Plasma lipids (mmolzl21)
Total cholesterol 4.6 6 0.2 4.6 6 0.2
LDL-cholesterol 2.4 6 0.2 2.5 6 0.2
HDL-cholesterol 1.0 6 0.1 1.1 6 0.1
Triglycerides 2.7 6 0.4 2.2 6 0.3
Glycated hemoglobin (%) 8.5 6 0.4 7.9 6 0.3*
Fasting blood glucose (mmolzl21) 12.0 6 0.5 9.8 6 0.5*
MAP (mm Hg) 102 6 3 104 6 2
Resting HR (beats/min21) 70 6 3 66 6 3*
Values are means 6 SE. Exercise training significantly decreased glycated hemoglo-
bin, fasting blood glucose and resting heart rate (*p , 0.05). No significant differences
were evident for other variables.
HDL 5 high density lipopiotein; HR 5 heart rate; LDL 5 low density
lipoprotein; MAP 5 mean arterial pressure.
Figure 1. (A) Endothelium-dependent, flow-mediated dilation (FMD)
and (B) endothelium-independent glyceryl trinitrate (GTN; nitroglycerin)-
mediated dilation of the brachial artery (n 5 15). Data from individual
subjects and mean values (6SE) are plotted for results following eight
weeks of inactivity (open circle) and eight weeks of exercise training
(closed circle). Endothelium-dependent FMD response was significantly
greater following training (p , 0.001, paired t test).
Table 2. Forearm Blood Flow: Values in Infused Arm During
Drug Infusions Compared to Preceding Baselines
Untrained Trained
ACh infusion
10 mg/min 1.5 6 0.2 2.1 6 0.5
20 mg/min 2.3 6 0.4 3.6 6 0.5
40 mg/min 4.3 6 0.6 5.2 6 1.0
SNP infusion
2 mg/min 3.1 6 0.3 3.6 6 0.4
4 mg/min 4.3 6 0.4 5.1 6 0.4
8 mg/min 5.7 6 0.6 7.0 6 0.7
Values are means 6 SE. The increase in forearm blood flow responses to acetylcholine
(ACh) in the infused arm after exercise training did not reach conventional
significance (p 5 0.06, two-way analysis of variance [ANOVA] but did so (p , 0.05)
when expressed as a ratio with flow in the noninfused arm (Fig. 2). Responses to
sodium nitroprusside (SNP) were not significantly different when compared to
preceding baselines (p 5 0.16, two-way ANOVA) or when expressed as a ratio with
flow in the noninfused arm (p 5 0.6, two-way ANOVA).
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largely NO dependent, significantly increased. In contrast,
no significant changes in resistance vessel response to SNP
or conduit artery response to GTN were apparent, although
there was a trend toward improved resistance vessel response
to SNP. These findings suggest that resistance and conduit
vessel vasodilator function are enhanced by exercise training
in type 2 diabetic patients. This adaptation appears to be
predominantly endothelium dependent, although other
mechanisms, such as increased smooth muscle sensitivity to
NO or structural changes, cannot be ruled out.
Exercise training and vascular function. Data from ani-
mal studies strongly suggest that exercise training or chronic
increases in flow induce improvement in NO-dependent
vascular function (9,23), including upregulation of consti-
tutive endothelial NO-synthase expression (10,11). In ad-
dition, recent studies have investigated the effect of exercise
training in humans. We demonstrated that an exercise
training program similar to that used in the present study
improved endothelium-dependent and -independent vascu-
lar function in patients with cardiac failure (16). This
accords with other studies in such patients; four weeks of
local forearm training improved forearm conduit artery
flow-dependent vasodilation, an effect attenuated by infu-
sion of the inhibitor of NO synthesis, NG-monomethyl-L-
arginine (L-NMMA) (13). Also, an eight-week forearm
training program improved local flow responses to ACh,
whereas endothelium-independent responses were unal-
tered (15), and six months of cycle training improved basal
and stimulated endothelium-dependent, NO-related re-
sponses in the lower limb (14). In addition, four weeks of
cycle ergometer training improved basal NO function in
forearm resistance vessels of healthy volunteers (12). How-
ever, the present findings are the first to demonstrate an
effect of exercise training in type 2 diabetic patients, and in
addition, no previous investigation has combined assess-
ment of both conduit and resistance vessel function. The
potential clinical relevance of these findings is highlighted
by the critical role of NO as an antiatherogenic molecule
(5), the high levels of cardiovascular mortality and morbidity
in type 2 diabetes and previous findings that interventions
which improve endothelial function (2–4,14,24) are also
associated with improved mortality and morbidity.
The beneficial effects of an exercise program on vascular
function probably relate to increasing flow and shear stress
on the endothelium, although general metabolic effects may
also contribute. There is evidence that FMD in conduit
vessels is largely dependent on endothelial release of NO
(13,18,25–28), as is resistance vessel dilation and hence
exercise-induced hyperemia (29–31). Experimentally, re-
peated exercise induces a sustained increase in endothelial
NO-synthase (10,11), implying chronic adaptation of the
NO-vasodilator system. It might be expected that an
increase in shear stress would not only result from increased
blood flow but also from other hemodynamic variables such
as increased HR and blood pressure, as well as metabolic
effects that would be imposed throughout the vasculature.
Figure 2. Forearm blood flow (FBF) response to three doses of (A)
acetylcholine (ACh) and (B) sodium nitroprusside (SNP) following eight
weeks of inactivity (open circle) or eight weeks of exercise training (closed
square) (n 5 16). Forearm blood flow is expressed as the percentage
change in the ratio of infusion arm to noninfusion arm flows relative to the
baseline period preceding the administration of ACh. Values are means 6
SE. Vasodilation to ACh was significantly increased by exercise training
(p , 0.05, two-way analysis of variance). The difference in response to
SNP was not significant (p 5 0.6, ANOVA).
Figure 3. Acetylcholine (ACh) responses following eight weeks of inac-
tivity in the group trained first (closed square) (n 5 6) and the group
trained second (open circle) (n 5 10). Values are means 6 SE. The
difference between the subgroups was not significantly different at any dose
(p 5 0.2), indicating that the effect of exercise training did not persist.
FBF 5 forearm blood flow
864 Maiorana et al. JACC Vol. 38, No. 3, 2001
Exercise and Vascular Function in Diabetes September 2001:860–6
This hypothesis would explain why the improvement in
vascular function in this study was evident in the upper
limb, whereas our exercise program was designed to be one
that excluded exercise of the upper limb. That is, the
beneficial effect of exercise training appears to be general-
ized and not restricted to the vascular bed of the specifically
trained skeletal muscle. This phenomenon has been recently
reported and described (16,32).
Alternative mechanistic explanations may relate to the
effect of exercise training on advanced glycation products.
Such products are associated with depressed NO function
(33,34), and glycated hemoglobin concentration decreased
as a result of exercise training in the present study. Fasting
blood glucose also decreased, consistent with decreased
insulin resistance (17,35–41). This constitutes another pos-
sible mechanism for improved vascular function as insulin
stimulates the production of NO through the insulin recep-
tor, the effector pathway having some commonality with
that for glucose transport (42). Because muscle glucose
uptake is dependent, in part, upon skeletal muscle blood
flow, the training-induced increase in vasodilator function
may contribute to the improved glycemic control, and vice
versa, as just outlined. However, in the present study,
neither the changes in glycated hemoglobin nor in fasting
blood glucose concentrations were correlated with changes
in ACh or in FMD responses. A further potential explana-
tion could have been training-induced changes in blood
lipid concentrations, as suggested by a recent cross-sectional
study (43) demonstrating enhanced ACh responses in the
“untrained” forearms of runners who had low plasma cho-
lesterol. This explanation appears unlikely, because vascular
function improved in the present study in the absence of
change in blood lipid concentrations, although training-
induced changes in lipid metabolism cannot be excluded
(38). Finally, it is possible that exercise training modulates
the effect of reactive oxygen species on NO bioavailability or
stimulates other relevant hormonal responses. The precise
mechanisms responsible for exercise training–induced
changes in vascular function remain to be determined.
Effect of detraining. Because the nontrained data did not
differ between the groups training first or second, it does not
appear that the effect of exercise training on the vasculature
persisted for eight weeks. This is consistent with the
time-course of deconditioning associated with other physi-
ologic adaptations to exercise training, such as skeletal
muscle metabolic changes (44), which reverse within four to
six weeks of exercise cessation. In addition, it accords with
the reversal of improvement in FMD of the brachial artery
observed six weeks after the cessation of forearm hand-grip
exercise in patients with heart failure (13). Therefore, it is
likely that an exercise program, at some level as yet unde-
termined, would be necessary to maintain the vascular
benefits of exercise.
Summary. Finally, this study indicates that an exercise
training program improves indices of glycemic control,
aerobic exercise tolerance and conduit, and resistance vessel
endothelial vasodilator function in patients with type 2
diabetes. The latter findings have particularly important
clinical significance in diabetes; improvement in endothelial
function often parallels antiatherogenic benefits, and vascu-
lar complications account for most deaths in type 2 diabetic
patients. An exercise program should be considered an
integral component of diabetic management for all patients
capable of participation.
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